Systemic lupus erythematosus is associated with an increased risk for pulmonary manifestations, including ILD and pulmonary hypertension.

All-cause mortality increased in 2020 to 2021 nationwide, with a slower increase in Medicaid expansion states, according to a study.

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

The inability to pay for health care has reached its highest point in the United States, according to the results of a survey.

Children born to anti-Ro antibody-positive mothers do not exhibit a greater prevalence of allergic, neurodevelopmental, or autoimmune conditions.

The FDA has approved a prefilled syringe formulation of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) that allows patients to self-inject the medication.

No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

People covered by Medicaid are just as likely as those with private insurance to face a copay or other charge for sending a message to their physician or other provider through a portal.

Prescribing medical cannabis to patients with chronic health conditions may improve health-related quality of life (HRQL).

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce the risk of dementia or cognitive impairment.

Community-level SDOH such as household income, neighborhood walkability, and healthcare access play a greater role in predicting THA outcomes than patient race.